{"id":"W2979752621","doi":"10.1182/blood.v114.22.2363.2363","title":"Fludarabine (F) and Rituximab (R) (FR) as Initial Therapy for Symptomatic Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL): Population-Based Experience Matches Clinical Trials.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; St. Paul's Hospital; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Medicine; Fludarabine; Internal medicine; Rituximab; Chronic lymphocytic leukemia; Population; Cyclophosphamide; Gastroenterology; Oncology; Surgery; Lymphoma; Leukemia; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01188184,0.000423805,0.001100824,0.0003805138,0.0003599814,0.000927017,0.0005243492,0.001000442,0.00196846],"category_scores_gemma":[0.01135974,0.0002895225,0.0007128321,0.0008896129,0.0006945186,0.0006266333,0.0004762048,0.0009743914,0.0003847958],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001034288,"about_ca_system_score_gemma":0.002024028,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002210306,"about_ca_topic_score_gemma":0.00327903,"domain_scores_codex":[0.9949028,0.003951371,0.0003286517,0.000297524,0.0003105502,0.0002091477],"domain_scores_gemma":[0.9954803,0.00219623,0.001034562,0.0002310406,0.0003650292,0.0006928095],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4859979,0.02387518,0.1094461,0.003985083,0.004895844,0.0006919299,0.001810846,0.0009904606,0.01007704,0.0003740559,0.007085278,0.3507701],"study_design_scores_gemma":[0.3736635,0.409564,0.1823668,0.0009541741,0.006323497,0.001747194,0.0007127335,0.0009421017,0.002709433,0.0005253824,0.02039746,0.00009379751],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9673681,0.02374864,0.0007436917,0.0007729019,0.00006860188,0.003241433,0.0009807327,0.00005078339,0.003025182],"genre_scores_gemma":[0.9850613,0.008881333,0.001556362,0.000852147,0.0001306026,0.001724801,0.001188772,0.00001048338,0.0005941974],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01188184,"threshold_uncertainty_score":0.06283796,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1132283951559305,"score_gpt":0.429709454932312,"score_spread":0.3164810597763815,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}